Tag: Competition

Displaying 1601 - 1620 of 2235 results.

Pages

In December 2008, the Commission settled antitrust concerns raised by the proposed $8.9 billion acquisition of Barr Pharmaceuticals by Teva Pharmaceutical Industries. The proposed acquisition would have lessened competition in the markets for 17 commonly used generic medications...
Following a public comment period, the Commission has approved a final consent order in the matter concerning Fresenius Medical Care AG & Co. KGaA/Daiichi Sankyo Company, Ltd. The vote approving the final order was 4-0. (FTC File No. 081-0146; the staff contact is Elizabeth A. Jex, Bureau of...
Commission issuance of order in matter of Rambus, Inc. - The Commission has issued an order in Rambus, Inc., Docket No. 9302, authorizing Rambus to receive royalties in excess of maximum allowable rates, as provided in the Commission's final order in this matter. The Commission's order was issued...
Today, the Federal Trade Commission announced a consent agreement and order that settle charges that Golf Galaxy, a subsidiary of Dick’s Sporting Good’s Inc., violated federal law by illegally agreeing with a potential competitor, Golf Canada, to allocate the market for golf merchandise in the...
In October of 2008, the Commission issued a consent order to settle charges that Golf Galaxy, a subsidiary of Dick’s Sporting Goods Inc., entered into an illegal agreement with Golf Canada to allocate the market for golf merchandise in the United States and Canada. The agreement...
The Federal Trade Commission today announced the agenda and panelists for its upcoming workshop on Section 5 of the FTC Act. The workshop will be held on October 17, 2008, and will consider the appropriate scope of Section 5’s prohibition on “unfair methods of competition.”
The FTC challenged Hexion LLC's proposed acquisition of Huntsman Corp., and settled its charges with a proposed consent order which requiredthe divestiture of Hexion's specialty epoxy business, and prevented the sharing of sensitive and non-public information which could lead to...
Hexion LLC has agreed to settle Federal Trade Commission charges that its proposed $10.6 billion acquisition of rival chemical manufacturer Huntsman Corporation would violate antitrust laws by substantially lessening competition in the North American markets for various end-use markets for...
– Following a public comment period, the Commission has approved the issuance of a final consent order and letters to the commenters of record in the matter concerning Negotiated Data Solutions, LLC. The vote approving issuance of the final order was 3-1, with Chairman William E. Kovacic voting no...
Commission approval of public comment period extension – The Commission has approved the publication of a Federal Register notice extending the pubic comment period related to the current regulatory review of the Used Motor Vehicle Trade Regulation Rule (Used Car Rule) through November 19, 2008....
The Federal Trade Commission today issued a complaint charging that Reed Elsevier Inc.’s (Reed Elsevier) proposed $4.1 billion acquisition of ChoicePoint Inc. (ChoicePoint) would be anticompetitive and in violation of the antitrust laws, as it would combine the two largest providers of electronic...
In September, 2008, the Commission challenged Reed Elsevier’s $4.1 billion proposed acquisition of ChoicePoint, which would have combined the two leading providers of electronic public record services provided to U.S. law enforcement customers. Public records services compile public...
The Federal Trade Commission today announced a complaint challenging Fresenius Medical Care Ag & Co. KGaA’s (Fresenius) proposed acquisition of an exclusive sublicense from Luitpold Pharmaceuticals, Inc. (Luitpold), a wholly owned U.S. subsidiary of the Japanese firm Daiichi Sankyo Company,...
The Federal Trade Commission urges consumers to be cautious of potential charity scams in connection with the damage caused by hurricanes Ike and Gustav along the Gulf Coast and in the Midwest.
The Commission challenged Fresenius Medical Care’s proposed purchase of an exclusive sublicense for the manufacture and supply of the drug Venofer to US dialysis clinics from Daiichi Sankyo Company. Venofer is an intravenously administered iron sucrose preparation used primarily to...
The Federal Trade Commission will be working with the Department of Energy (DOE) and state regulatory agencies to ensure consumers are being treated fairly in the wake of hurricanes Ike and Gustav.
The Federal Trade Commission has advice for people who find themselves in the path of Hurricane Ike. A special Web site set up by the agency provides preparedness tips and information about recovery. Consumers who may be affected by Hurricane Ike can go to: http://www.ftc.gov/bcp/edu/microsites/...
In a joint statement to the Illinois Task Force on Health Planning Reform, the Federal Trade Commission and Department of Justice (DOJ) stated the agencies’ position regarding certificate-of-need (CON) laws, saying that the laws undercut consumer choice, stifle innovation and weaken markets’...
The Federal Trade Commission today issued a Final Order on Remand from the Fifth Circuit Court of Appeals in the matter of North Texas Specialty Physicians v. FTC, 528 F.3d 346 (5th Cir. 2008). The FTC’s Final Order on Remand modifies the text in one paragraph of the remedial order (Paragraph II.A...
The Federal Trade Commission today announced that the Bureau of Competition’s Premerger Notification Office will host a half-day workshop on the basics of the U.S. premerger notification program in Washington, DC, on October 23, 2008.

Pages